Table 1 Groups of vaccinated mice in the present study
From: Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice
Mice group | Prime | Boost | Challenge | Modality |
|---|---|---|---|---|
G1 | L. tarentolae-LACK/KMP11/EGFP adjuvant CpG | L. tarentolae-LACK/KMP11/EGFP adjuvant CpG | L. major | rLive vaccine |
G2 | L. tarentolae-LACK/KMP11/EGFP adjuvant nCpG | L. tarentolae-LACK/KMP11/EGFP adjuvant non-CpG | L. major | rLive vaccine |
G3 | L. tarentolae-EGFP adjuvant CpG | L. tarentolae-EGFP adjuvant CpG | L. major | Control |
G4 | L. tarentolae-EGFP adjuvant nCpG | L. tarentolae-EGFP adjuvant non-CpG | L. major | Control |
G5 | PBS | PBS | L. major | Control |